Market Research Logo

Veterinary Vaccines - Global Market Outlook (2017-2026)

Veterinary Vaccines - Global Market Outlook (2017-2026)

According to Stratistics MRC, the Global Veterinary Vaccines Market is accounted for $6.44 billion in 2017 and is expected to reach $11.73 billion by 2026 growing at a CAGR of 6.9% from 2017 to 2026. Growing figure of livestock disease, Increasing Adoption of Companion Animals and Rising frequency of Zoonotic diseases are some of the factors that are fuelling the market growth. On the other side, high costs are hampering the market growth. However, Awareness in emerging country regarding animal health provides ample opportunity to the market. Veterinary vaccines are important for animal health, animal welfare, food production, and public health. They are a cost-effective method to prevent animal disease among animals as well as humans.

On the basis of technology, DNA Vaccines uses a gene from a virus or bacteria to stimulate the immune system. They can be made in a short time span it is easier to make large amounts of a gene than make proteins or grow up bacteria or viruses. Speed is important when making a vaccine to strains of bacteria or virus that are constantly mutating and changing and does not need to be stored at low temperatures making transportation and storage cheaper and easier than conventional vaccines.

North America by geography among all other regions is expected to have highest market share throughout the forecasting period due to the awareness for prevention of animal-to-human transmission diseases and lower investment in research and development in the animal vaccine on compared to human vaccine area may propel the Veterinary Vaccines market.

Some of the key players of veterinary vaccines market include Jinyu Bio-Technology, China Animal Husbandry, Tianjin Ringpu, Biogenesis Bago, Idt Biologika, Hipra, Hester, Phibro Animal Health, Vetoquinol, Virbac, Merck Animal Health, Zoetis, Boehringer Ingelheim, Elanco and Ceva.

Types Covered:
• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Companion Animal Vaccines
• Cattle Vaccines
• Aquaculture Vaccines
• Veterinary Viral Vaccines
• Veterinary Bacterial Vaccines
• Veterinary Parasite Vaccines
• Veterinary Vaccines for Infectious Diseases
• Other Animal Vaccines

Technologies Covered:
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Subunit vaccines
• DNA vaccines
• Conjugate vaccines
• Other Vaccines

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Veterinary Vaccines Market, By Type
5.1 Introduction
5.2 Porcine Vaccines
5.2.1 Porcine Parvovirus
5.2.2 Porcine Reproductive Respiratory Syndrome
5.2.3 Porcine Circovirus II
5.2.4 Swine Influenza
5.2.5 Auzeszky’s Disease
5.2.6 Swine Pneumonia
5.3 Poultry Vaccines
5.3.1 Bronchits
5.3.2 Avian influenza
5.3.3 Newcastle disease
5.3.4 Marek's disease
5.4 Livestock Vaccines
5.4.1 Bovine Vaccines
5.4.1.1 Bovine Viral Diarrhea
5.4.1.2 Brucellosis
5.4.1.3 Foot and mouth disease
5.4.1.4 Bovine Clostridial disease
5.4.1.5 Infectious Bovine Rhinotracheitis
5.4.2 Small Ruminant Vaccines
5.5 Companion Animal Vaccines
5.5.1 Canine Vaccines
5.5.1.1 Distemper
5.5.1.2 Kennel cough (Parainfluenza)
5.5.1.3 Parvovirus
5.5.1.4 Canine herpes
5.5.1.5 Lyme Disease
5.5.2 Equine Vaccines
5.5.2.1 Rhinopneumonitis
5.5.2.2 Influenza
5.5.2.3 Encephalomyelitis
5.5.2.4 Strangles
5.5.2.5 Tetanus
5.5.3 Feline Vaccines
5.5.3.1 Feline calicivirus
5.5.3.2 Peritonitis (FIP)
5.5.3.3 Feline FIV
5.6 Cattle Vaccines
5.6.1 BRSV
5.6.2 Enzootic Bronchopneu
5.6.3 IBR
5.6.4 BVD/MD
5.7 Aquaculture Vaccines
5.8 Veterinary Viral Vaccines
5.8.1 Live Viral Vaccines
5.8.2 Inactivated Viral Vaccines
5.8.3 DIVA Vaccines (Differentiating Infected from Vaccinated Animals)
5.8.4 Molecularly Defined Subunit Vaccines
5.8.5 Genetically Engineered Viral Vaccines
5.8.6 Live Viral Vector Vaccines
5.8.7 DNA Vaccines
5.9 Veterinary Bacterial Vaccines
5.9.1 Conventional Live Vaccines
5.9.2 Conventional Inactivated Vaccines
5.9.3 Gene-Deleted Vaccines
5.9.4 Subunit Vaccines
5.10 Veterinary Parasite Vaccines
5.10.1 Protozoal Vaccines
5.10.2 Subunit Protozoal Parasite Vaccines
5.10.3 Helminth and Ectoparasite Vaccines
5.11 Veterinary Vaccines for Infectious Diseases
5.11.1Allergy Vaccines
5.11.2 Cancer Vaccines
5.12 Other Animal Vaccines
6 Global Veterinary Vaccines Market, By Technology
6.1 Introduction
6.2 Live Attenuated Vaccines
6.3 Inactivated Vaccines
6.4 Toxoid Vaccines
6.5 Recombinant Vaccines
6.6 Subunit vaccines
6.7 DNA vaccines
6.8 Conjugate vaccines
6.9 Other Vaccines
7 Global Veterinary Vaccines Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Acquisitions & Mergers
8.2 Agreements, Partnerships, Collaborations and Joint Ventures
8.3 Product Launch & Expansions
8.4 Other Activities
9 Company Profiling
9.1 Bayer Healthcare
9.2 Jinyu Bio-Technology
9.3 Tianjin Ringpu
9.4 Biogenesis Bago
9.5 Idt Biologika
9.6 Hipra
9.7 Hester
9.8 Phibro Animal Health
9.9 Vetoquinol
9.10 Virbac
9.11 Merck Animal Health
9.12 Zoetis animal healthcare
9.13 Boehringer Ingelheim
9.14 Elanco
9.15 Ceva
9.16 China Animal Husbandry
9.17 Embrex Inc.
9.18 Fort Dodge Animal Health
9.19 Imugene Limited
9.20 Bioniche Animal Health
List of Tables
Table 1 Global Veterinary Vaccines Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Veterinary Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 3 Global Veterinary Vaccines Market Outlook, By Porcine Vaccines (2016-2026) ($MN)
Table 4 Global Veterinary Vaccines Market Outlook, By Porcine Parvovirus (2016-2026) ($MN)
Table 5 Global Veterinary Vaccines Market Outlook, By Porcine Reproductive Respiratory Syndrome (2016-2026) ($MN)
Table 6 Global Veterinary Vaccines Market Outlook, By Porcine Circovirus II (2016-2026) ($MN)
Table 7 Global Veterinary Vaccines Market Outlook, By Swine Influenza (2016-2026) ($MN)
Table 8 Global Veterinary Vaccines Market Outlook, By Auzeszky’s Disease (2016-2026) ($MN)
Table 9 Global Veterinary Vaccines Market Outlook, By Swine Pneumonia (2016-2026) ($MN)
Table 10 Global Veterinary Vaccines Market Outlook, By Poultry Vaccines(2016-2026) ($MN)
Table 11 Global Veterinary Vaccines Market Outlook, By Bronchits (2016-2026) ($MN)
Table 12 Global Veterinary Vaccines Market Outlook, By Avian influenza (2016-2026) ($MN)
Table 13 Global Veterinary Vaccines Market Outlook, By Newcastle disease (2016-2026) ($MN)
Table 14 Global Veterinary Vaccines Market Outlook, By Marek's disease (2016-2026) ($MN)
Table 15 Global Veterinary Vaccines Market Outlook, By Livestock Vaccines(2016-2026) ($MN)
Table 16 Global Veterinary Vaccines Market Outlook, By Bovine Vaccines (2016-2026) ($MN)
Table 17 Global Veterinary Vaccines Market Outlook, By Small Ruminant Vaccines (2016-2026) ($MN)
Table 18 Global Veterinary Vaccines Market Outlook, By Companion Animal Vaccines(2016-2026) ($MN)
Table 19 Global Veterinary Vaccines Market Outlook, By Canine Vaccines (2016-2026) ($MN)
Table 20 Global Veterinary Vaccines Market Outlook, By Equine Vaccines (2016-2026) ($MN)
Table 21 Global Veterinary Vaccines Market Outlook, By Feline Vaccines (2016-2026) ($MN)
Table 22 Global Veterinary Vaccines Market Outlook, By Cattle Vaccines (2016-2026) ($MN)
Table 23 Global Veterinary Vaccines Market Outlook, By BRSV (2016-2026) ($MN)
Table 24 Global Veterinary Vaccines Market Outlook, By Enzootic Bronchopneu (2016-2026) ($MN)
Table 25 Global Veterinary Vaccines Market Outlook, By IBR (2016-2026) ($MN)
Table 26 Global Veterinary Vaccines Market Outlook, By BVD/MD (2016-2026) ($MN)
Table 27 Global Veterinary Vaccines Market Outlook, By Aquaculture Vaccines(2016-2026) ($MN)
Table 28 Global Veterinary Vaccines Market Outlook, By Veterinary Viral Vaccines (2016-2026) ($MN)
Table 29 Global Veterinary Vaccines Market Outlook, By Live Viral Vaccines (2016-2026) ($MN)
Table 30 Global Veterinary Vaccines Market Outlook, By Inactivated Viral Vaccines (2016-2026) ($MN)
Table 31 Global Veterinary Vaccines Market Outlook, By DIVA Vaccines (Differentiating Infected from Vaccinated Animals) (2016-2026) ($MN)
Table 32 Global Veterinary Vaccines Market Outlook, By Molecularly Defined Subunit Vaccines (2016-2026) ($MN)
Table 33 Global Veterinary Vaccines Market Outlook, By Genetically Engineered Viral Vaccines (2016-2026) ($MN)
Table 34 Global Veterinary Vaccines Market Outlook, By Live Viral Vector Vaccines (2016-2026) ($MN)
Table 35 Global Veterinary Vaccines Market Outlook, By DNA Vaccines (2016-2026) ($MN)
Table 36 Global Veterinary Vaccines Market Outlook, By Veterinary Bacterial Vaccines (2016-2026) ($MN)
Table 37 Global Veterinary Vaccines Market Outlook, By Conventional Live Vaccines (2016-2026) ($MN)
Table 38 Global Veterinary Vaccines Market Outlook, By Conventional Inactivated Vaccines (2016-2026) ($MN)
Table 39 Global Veterinary Vaccines Market Outlook, By Gene-Deleted Vaccines (2016-2026) ($MN)
Table 40 Global Veterinary Vaccines Market Outlook, By Subunit Vaccines (2016-2026) ($MN)
Table 41 Global Veterinary Vaccines Market Outlook, By Veterinary Parasite Vaccines (2016-2026) ($MN)
Table 42 Global Veterinary Vaccines Market Outlook, By Protozoal Vaccines (2016-2026) ($MN)
Table 43 Global Veterinary Vaccines Market Outlook, By Subunit Protozoal Parasite Vaccines (2016-2026) ($MN)
Table 44 Global Veterinary Vaccines Market Outlook, By Helminth and Ectoparasite Vaccines (2016-2026) ($MN)
Table 45 Global Veterinary Vaccines Market Outlook, By Veterinary Vaccines for Infectious Diseases (2016-2026) ($MN)
Table 46 Global Veterinary Vaccines Market Outlook, By Allergy Vaccines (2016-2026) ($MN)
Table 47 Global Veterinary Vaccines Market Outlook, By Cancer Vaccines (2016-2026) ($MN)
Table 48 Global Veterinary Vaccines Market Outlook, By Other Animal Vaccines (2016-2026) ($MN)
Table 49 Global Veterinary Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 50 Global Veterinary Vaccines Market Outlook, By Live Attenuated Vaccines(2016-2026) ($MN)
Table 51 Global Veterinary Vaccines Market Outlook, By Inactivated Vaccines(2016-2026) ($MN)
Table 52 Global Veterinary Vaccines Market Outlook, By Toxoid Vaccines(2016-2026) ($MN)
Table 53 Global Veterinary Vaccines Market Outlook, By Recombinant Vaccines(2016-2026) ($MN)
Table 54 Global Veterinary Vaccines Market Outlook, By Subunit vaccines (2016-2026) ($MN)
Table 55 Global Veterinary Vaccines Market Outlook, By DNA vaccines (2016-2026) ($MN)
Table 56 Global Veterinary Vaccines Market Outlook, By Conjugate vaccines (2016-2026) ($MN)
Table 57 Global Veterinary Vaccines Market Outlook, By Other Vaccines (2016-2026) ($MN)
NOTE:North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in above manner.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report